Sarah Skrzypczyk
Overview
Explore the profile of Sarah Skrzypczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anft M, Wiemers L, Rosiewicz K, Doevelaar A, Skrzypczyk S, Kurek J, et al.
Mol Ther
. 2025 Jan;
PMID: 39797400
Autoantibodies (AABs) are currently being investigated as causative or aggravating factors during post-COVID. In this study, we analyze the effect of immunoadsorption therapy on symptom improvement and the relationship with...
2.
Anft M, Zgoura P, Skrzypczyk S, Durr M, Viebahn R, Westhoff T, et al.
Front Transplant
. 2024 Oct;
3:1405070.
PMID: 39386200
Background: LCP-Tacro [LCPT], a novel once-daily, extended-release formulation of tacrolimus, has a reduced C with comparable AUC exposure, requiring a ∼30% dose reduction in contrast to immediate-release tacrolimus (IR-Tac). Once-daily...
3.
Stumpf J, Anders L, Siepmann T, Schwobel J, Karger C, Lindner T, et al.
Vaccine
. 2023 Dec;
42(2):120-128.
PMID: 38114410
Background: SARS-CoV-2mRNA vaccination related seroconversion rates are reduced in dialysis and kidney transplant patients. Methods: We evaluated nine months follow up data in our observational Dia-Vacc study exploring specific cellular...
4.
Seibert F, Stervbo U, Wiemers L, Skrzypczyk S, Hogeweg M, Bertram S, et al.
Autoimmun Rev
. 2023 Sep;
22(11):103445.
PMID: 37689093
Background: The Long-COVID syndrome constitutes a plethora of persisting symptoms with neurological disorders being the most disabling ones. The pathogenesis of Long-COVID is currently under heavy scrutiny and existing data...
5.
Anft M, Skrzypczyk S, Frahnert M, Fricke L, Zapka J, Kuhn D, et al.
Kidney Int Rep
. 2023 Jan;
8(4):939-941.
PMID: 36712412
No abstract available.
6.
Anft M, Skrzypczyk S, Frahnert M, Fricke L, Zapka J, Kuhn D, et al.
Kidney Int Rep
. 2023 Jan;
8(3):685-687.
PMID: 36644711
No abstract available.
7.
Paniskaki K, Anft M, Thieme C, Skrzypczyk S, Konik M, Dolff S, et al.
Transplant Proc
. 2022 Apr;
54(6):1455-1464.
PMID: 35489983
Background: Immune responses to seasonal endemic coronaviruses might have a pivotal role in protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Those SARS-CoV-2-crossreactive T cells were recently described in...
8.
Bertram S, Blazquez-Navarro A, Seidel M, Holzer B, Seibert F, Doevelaar A, et al.
Sci Rep
. 2022 Apr;
12(1):6243.
PMID: 35422075
Healthcare workers are at substantially increased risk for infection with SARS-CoV-2. Successful vaccination constitutes a crucial prerequisite to protect this group during the pandemic. Since post vaccination antibody monitoring is...
9.
Paniskaki K, Anft M, Meister T, Marheinecke C, Pfaender S, Skrzypczyk S, et al.
Front Immunol
. 2022 Feb;
13:816220.
PMID: 35145522
SARS-CoV-2 variants of concern (VOCs) can trigger severe endemic waves and vaccine breakthrough infections (VBI). We analyzed the cellular and humoral immune response in 8 patients infected with the alpha...
10.
Westhoff T, Seibert F, Anft M, Blazquez-Navarro A, Skrzypczyk S, Zgoura P, et al.
Kidney Int
. 2021 Sep;
100(5):1135-1136.
PMID: 34509489
No abstract available.